M. Schiffman, J. Doorbar, N. Wentzensen, S. De-sanjosé, C. Fakhry et al., , vol.562


S. Shanmugasundaram and J. You, Targeting persistent human 622 papillomavirus infection, Viruses, vol.9, 2017.

A. De-cian, E. Delemos, and J. Mergny, Teulade-Fichou, p.624

D. Monchaud, Highly efficient G-quadruplex recognition by bisquinolinium 625 compounds, Journal of the American Chemical Society, vol.129, pp.1856-1857, 2007.


J. Carvalho, T. Quintela, N. M. Gueddouda, A. Bourdoncle, and J. Mergny, , p.628

G. F. Salgado, J. A. Queiroz, C. , and C. , Phenanthroline polyazamacrocycles 629 as G-quadruplex DNA binders, Organic and Biomolecular Chemistry, vol.16, pp.2776-2786, 2018.


M. Read, R. J. Harrison, B. Romagnoli, F. A. Tanious, S. H. Gowan et al.,

P. Wilson, W. D. Kelland, L. R. Neidle, and S. , Structure-based design of 633 selective and potent G quadruplex-mediated telomerase inhibitors, Proceedings of the 634 National Academy of Sciences of the United States of America, vol.98, pp.4844-4853, 2001.


J. Carvalho, E. Pereira, J. Marquevielle, M. P. Campello, and J. Mergny, , p.637

A. Paulo, G. F. Salgado, J. A. Queiroz, C. , and C. , , 2018.

, acridine orange derivatives bind and stabilize KRAS-22RT G-quadruplex, Biochimie, vol.639, issue.144, pp.144-152

S. R-d-g-z-r-m, J. A. Yeoman, C. Trentesaux, and J. Riou, , p.641

S. Balasubramanian, A Novel Small Molecule That Alters Shelterin Integrity 642 and Triggers a DNA-Damage Response at Telomeres, Journal of the American, vol.643, 2008.

E. Largy, F. Hamon, and M. Teulade-fichou, , 2011.

, throughput G4-FID assay for screening and evaluation of small molecules binding 686 quadruplex nucleic acid structures, Analytical and Bioanalytical Chemistry, vol.400, pp.3419-687

M. Webba-da-silva, NMR methods for studying quadruplex nucleic acids, 2007.

, Methods, vol.43, pp.264-277

I. Bessi, J. Wirmer-bartoschek, J. Dash, and H. Schwalbe, Targeting G-691 quadruplex with Small Molecules: An NMR View, in Modern Magnetic Resonance, pp.1-22, 2017.

J. Dai, M. Carver, L. H. Hurley, Y. , and D. , Solution structure of a 2:1 694 quindoline-c-MYC G-quadruplex: Insights into G-quadruplex-interactive small 695 molecule drug design, Journal of the American Chemical Society, vol.133, pp.17673-17680, 2011.


M. Adrian, B. Heddi, and A. T. Phan, NMR spectroscopy of G-698 quadruplexes, Methods, vol.57, pp.11-24, 2012.

A. De-rache and J. Mergny, Assessment of selectivity of G-quadruplex 700 ligands via an optimised FRET melting assay, Biochimie, vol.115, pp.194-202, 2015.


D. A. Drubin, M. E. Mclaughlin-drubin, G. A. Clawson, and C. Meyers, , p.703, 2006.

, A Protease Inhibitor Specifically Inhibits Growth of HPV-Infected Keratinocytes

, Molecular Therapy, vol.13, pp.1142-1148

S. Banerjee, N. Moore, D. W. Broker, T. R. Chow, and L. T. , , p.706, 2018.

, Vorinostat, a pan-HDAC inhibitor, abrogates productive HPV-18 DNA amplification

, Proceedings of the National Academy of Sciences of the United States of America, vol.115, p.708

. E11138-e11147,

M. J. Lista, R. P. Martins, O. Billant, M. A. Contesse, S. Findakly et al., , p.710

C. Daskalogianni, C. Beauvineau, C. Guetta, C. Jamin, and M. P. Teulade-fichou, , p.711

R. Fåhraeus, C. Voisset, and M. Blondel, , 2017.

, Barr virus immune evasion through binding to G-quadruplexes of EBNA1 mRNA

, Nature Communications, vol.8, 16043.

E. Grinstein, P. Wernet, P. J. Snijders, F. Rösl, I. Weinert et al., , p.715

R. Schewe, C. Schwabe, M. Hauptmann, S. Dietel, M. Meijer et al., , p.716

H. Royer, Nucleolin as activator of human papillomavirus type 18 oncogene 717 transcription in cervical cancer, The Journal of Experimental Medicine, vol.196, pp.1067-1078, 2002.


S. Artusi, R. Perrone, S. Lago, P. Raffa, E. Di-iorio et al., Visualization of DNA G-quadruplexes in herpes simplex virus 1, vol.720, 2016.

, Nucleic Acids Research, vol.44, pp.10343-10353

O. I. El-sabbagh and H. M. Rady, Synthesis of new acridines and 723 d az d d m ?-diketone for cytotoxic and antiviral evaluation, 2009.

, European Journal of Medicinal Chemistry, vol.44, pp.3680-3686


J. R. Goodell, A. A. Madhok, H. Hiasa, and D. M. Ferguson, Synthesis 727 and evaluation of acridine-and acridone-based anti-herpes agents with topoisomerase 728 activity, Bioorganic and Medicinal Chemistry, vol.14, pp.5467-5480, 2006.


. R-a-j-d-b-?-?-v-?-m-b-?-j-a-d-?-d-a-o, 731 published data on acridine derivatives with different biological activities, Kragujevac 732 Journal of Science, pp.83-101, 2018.

M. Tonelli, G. Vettoretti, B. Tasso, F. Novelli, V. Boido et al., , p.734

B. Busonera, A. Ouhtit, P. Farci, S. Blois, G. Giliberti et al., , p.735, 2011.

, Acridine derivatives as anti-BVDV agents, Antiviral Research, vol.91, pp.133-141


Z. Hu and D. Ma, The precision prevention and therapy of HPV-related 738 cervical cancer: new concepts and clinical implications, Cancer Medicine, vol.7, pp.5217-739, 2018.

D. Piekna-przybylska, G. Sharma, S. B. Maggirwar, and R. A. Bambara, , p.741, 2017.

, Deficiency in DNA damage response, p.742